NMSS funds Adeona Pharma Trimesta clinical trial
Earlier, the company has received $5m grant from the NMSS in partnership with the NMSS’s Southern California chapter, with support from the National Institutes of Health, and $860,440
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.